top

04.19.10: CombiMatrix Corporation Announces Strategic and Operational Restructuring

top

08.16.10: CombiMatrix Provides Update on Financial Results and Strategic Restructuring -- Appoints Judd Jessup as Full-Time CEO

06.16.10: CombiMatrix to Deliver Keynote Speech at World Cancer Congress

06.15.10: CombiMatrix Diagnostics Cleared to Begin Medicare Billing

04.19.10: CombiMatrix Corporation Announces Strategic and Operational Restructuring

10.21.09: Combimatrix Molecular Diagnostics Strengthens Management Team

06.03.09: CombiMatrix Publishes Clinical Study of Its HerScan™ Breast Cancer Test

04.29.09: CombiMatrix Receives Commitments For $8.25 Million in Registered Direct Offering

04.20.09: Dr. Karine Hovanes Named Laboratory Director of Combimatrix Molecular Diagnostics

01.26.09: Lenetix to Co-Market Combimatrix Molecular Diagnostics' Suite of Developmental Genomics Array-Based Tests

01.21.09: Former FDA Deputy Commissioner Dr. Scott Gottlieb Joins CombiMatrix Board of Directors

top

12/18/08: CombiMatrix Announces Positive Results From Expanded HerScan Study

12/16/08: CombiMatrix Launches New Prostate Cancer Array-Based Diagnostic Test

09/30/08: CombiMatrix Launches Two New Array-Based Diagnostic Tests

09/26/08: CombiMatrix Ranked Number 12 in Deloitte's Technology Fast 50 Program for Washington State

09/08/08: CombiMatrix to Hold Conference Call to Discuss Recent Findings Utilizing Its HemeScan Test for Chronic Lymphocytic Leukemia Patients

08/12/08: CombiMatrix Announces Publication of Clinical Validation Study of the HemeScan Array for Chronic Lymphocytic Leukemia

08/05/08: Renowned Prostate Cancer Expert, Dr. Colin Collins, Joins CombiMatrix's Scientific Advisory Board

07/22/08: CombiMatrix's Newly Updated Autism Test Gains Market Attention

06/04/08: CombiMatrix Announces the Acceptance of Its Multi-Institute Study On the Use of HemeScan for CLL by Journal: View article

04/08/08: Combimatrix Launches BAC HD Scan: Diagnostic for Over 125 Genetic Disorders Including Autism Spectrum Disorder

02/26/08: CombiMatrix Molecular Diagnostics Announces the Validation and Launch of the HerScan Test for Assessment of Newly Diagnosed Breast Cancer

02/15/08: Genetic Diagnostics Expert, Dr. Kavita Reddy, Joins Combimatrix as Laboratory Director

01/31/08: Combimatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL)

01/17/08:New Discoveries Confirm and Enhance Combimatrix's Microarray Test for Autism

01/10/08:Recent Scientific Publications Confirm Importance of Combimatrix's Test for Autism

top

12/18/07:Combimatrix Molecular Diagnostics Launches Microarray Test for Detection of Autism Spectrum Disorder

09/25/07: Combimatrix Molecular Diagnostics Launches HemeScan MDS for the Management and Diagnosis of Myelodysplastic Syndromes

07/16/07: Combimatrix Molecular Diagnostics Launches Next Enhanced Version of Its Constitutional Genetic Array Test

06/25/07: Combimatrix Molecular Diagnostics Launches Hemescan™ Ploidy Test For The Management Of Acute Lymphoblastic Leukemia

05/01/07: Industry Veteran Dindyal Ramkissoon Joins Combimatrix Molecular Diagnostics As VP Of Sales And Marketing

03/20/07: Combimatrix Molecular Diagnostics Launches Next Version Of Its Constitutional Genetic Array Test And With It Enters The Prenatal Market

03/14/07: Combimatrix Molecular Diagnostics Launches Hemescan™ Prognostic For The Management Of Chronic Lymphocytic Leukemia

03/13/07: Combimatrix Molecular Diagnostics Launches Nationally Its Technical Only Program For Reference Laboratories

03/07/07: Combimatrix Molecular Diagnostics To Utilize Autism Probe Content From A Partnership With The Centre For Applied Genomics

02/22/07: Dr. Mansoor Mohammed Appointed CEO Of Combimatrix Molecular Diagnostics

top

11/10/06: Combimatrix Molecular Diagnostics Announces the Launch of Powerful New Melanoma Test

10/18/06: FDA Provides Positive Opinion on the Regulatory Status of Combimatrix's First Array-Based Molecular Diagnostic

9/5/06: Combimatrix Molecular Diagnostics Announces Commercial Launch of its First Genetic Test From its CLIA Certified Laboratory

7/24/06: Dr. Shelly Gunn Joins Combimatrix Molecular Diagnostics

6/26/06: Combimatrix Molecular Diagnostics To Offer First Commercial Genetic Test From Its CLIA Certified Laboratory

5/31/06: Renowned Genomics Expert, Stephen W. Scherer, Joins Combimatrix Molecular Diagnostics’ Science Advisory Board

4/17/06: Combimatrix Molecular Diagnostics Launches and Ships First Microarray Diagnostic Product Ahead of Schedule

4/17/06: Combimatrix Molecular Diagnostics Receives Accreditation from the College of American Pathologists

4/10/06: Combimatrix Molecular Diagnostics Establishes A Facility In The State-Of-The-Art MaRS Discovery District in Toronto, Ontario, Canada

3/31/06: Combimatrix Molecular Diagnostics Receives CLIA Certification

3/14/06: Renowned Microarray And Genomics Expert Dr. Mansoor Mohammed, Joins Combimatrix Molecular Diagnostics

3/13/06: Combimatrix Molecular Diagnostics And Array Genomics Collaborate To Expand Diagnostic Microarray Technology Internationally

top

12/07/05: Combimatrix Molecular Diagnostics and University of California Los Angeles Researchers to Collaborate on Gene-Based Melanoma Test

12/06/05: Combimatrix Molecular Diagnostics to Test for Influenza; Service Will Enable Identification of (H5N1) Bird Flu

11/30/05: Renowned Pathologist Dr. Jonathan W. Said Joins Combimatrix Molecular Diagnostics’ Scientific Advisory Board

11/14/05: Renowned Pathologist Dr. Scott W. Binder Joins Combimatrix Molecular Diagnostics’ Scientific Advisory Board

7/12/05: Combimatrix Molecular Diagnostics Expands Management Team and Provides Operational Update

6/30/05: Combimatrix To Receive $2.9 Million from Registered Direct Offering

5/19/05: Combimatrix to Hold Conference Call to Discuss Business Strategy for Combimatrix Molecular Diagnostics

5/10/05: Combimatrix Forms Diagnostics Subsidiary: Combimatrix Molecular Diagnostics - Subsidiary To Be Led By Senior Industry Executives